Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 3 Representative immunofluorescence micrographs of human heart sections labeled for the nicotinamide adenine dinucleotide 3-phosphate (reduced form) oxidase subunit p47phox. (A) Dual labeling for p47phox and alpha-actinin in nonfailing (a–c) and end-stage failing tissue (b–f). Panels a and d show labeling for p47phox; panels b and e show labeling for alpha-actinin; panels c and f show superimposed images. p47phox was detected in cardiac myocytes in both failing and nonfailing myocardium, with increased sarcolemmal labeling in the failing group (d and f vs. a and c). All scale bars = 20 µm. (B) Dual labeling for p47phox and vinculin, as a sarcolemmal marker, in nonfailing (a–c) and end-stage failing tissue (b–f). Panels a and d show labeling for p47phox; panels b and e show labeling for vinculin. Superposition of the p47phox and vinculin images (panels c and f) demonstrates the sarcolemmal localization of p47phox in the end-stage heart tissue (panel f, yellow color). All scale bars = 20 µm.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement